Women's Health Research Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Department of Surgery, University of Cape Town, Cape Town, South Africa.
BMC Womens Health. 2020 Oct 6;20(1):224. doi: 10.1186/s12905-020-01094-3.
No known studies have been undertaken in South Africa exploring the contraceptive and fertility needs and preferences of women of reproductive age (18-49) diagnosed with breast cancer. This study set out to understand the contraceptive needs and fertility intentions of women with breast cancer in Cape Town, South Africa.
Qualitative in-depth interviews were conducted with 24 women diagnosed with breast cancer and 4 health care providers at a tertiary hospital in Cape Town, South Africa. We explored contraceptive use prior to diagnosis; the impact of breast cancer on future fertility intentions and contraceptive use; understanding of suitable contraceptive methods during and after treatment and women's fertility related counseling needs during their continuum of care. Data were analysed using a thematic analysis approach.
Since being diagnosed with breast cancer, of those women using a contraceptive method, the non-hormonal intrauterine device (IUD) was the most commonly used method. However, women reported receiving limited information from health care providers about contraceptive use and future fertility planning post treatment when fertility desires might change. Many women reported limited information received from healthcare providers about the impact of cancer treatment on their future fertility. Most women did not receive information around fertility preservation options, and few were familiar with the concept. Providers focus was more on preventing pregnancy during treatment and ensuring a patient was on a non-hormonal contraceptive method. Providers supported a more holistic, multidisciplinary approach to breast cancer patient's contraceptive and future fertility needs.
Limited contraceptive and future fertility counseling were reported by women despite many women being provided with the IUD. There is a need for improved information and counseling regarding the impact of treatment on contraceptive and fertility options. It is important that cancer care providers provide timely information regarding fertility options and communicate with patients about their fertility concerns prior to treatment and throughout the course of survivorship. The development of evidence-based information tools to enhance patient-provider communication and counseling could address knowledge gaps.
在南非,尚未有研究探索过被诊断患有乳腺癌的育龄期(18-49 岁)女性的避孕和生育需求及偏好。本研究旨在了解南非开普敦乳腺癌女性的避孕需求和生育意愿。
在南非开普敦的一家三级医院,对 24 名被诊断患有乳腺癌的女性和 4 名医疗保健提供者进行了定性深入访谈。我们探讨了诊断前的避孕措施使用情况;乳腺癌对未来生育意愿和避孕措施使用的影响;在治疗期间和治疗后对合适避孕方法的理解;以及女性在整个治疗过程中与生育相关的咨询需求。使用主题分析方法对数据进行分析。
自被诊断患有乳腺癌以来,在使用避孕方法的女性中,最常使用的是非激素宫内节育器(IUD)。然而,女性报告称,在治疗后生育意愿可能发生变化时,从医疗保健提供者那里获得的关于避孕和未来生育计划的信息有限。许多女性报告称,从医疗保健提供者那里获得的关于癌症治疗对未来生育影响的信息有限。大多数女性没有获得有关生育保存选择的信息,很少有人了解这个概念。提供者的重点更多地放在治疗期间预防怀孕和确保患者使用非激素避孕方法上。提供者支持对乳腺癌患者的避孕和未来生育需求采取更全面、多学科的方法。
尽管许多女性都被提供了 IUD,但报告称避孕和未来生育咨询有限。需要改进有关治疗对避孕和生育选择影响的信息和咨询。重要的是,癌症护理提供者应在治疗前和整个生存期间及时提供有关生育选择的信息,并与患者沟通他们的生育问题。开发基于证据的信息工具,以加强医患沟通和咨询,可以解决知识差距问题。